effrey Fowler, MD, John G. Boutselis Chair in Gynecologic Oncology and Professor and vice-chair of Obstetrics and Gynecology at The Ohio State University Wexner Medical Center in Columbus, started his one-year term as the 48th President of the...
22-Mar-2016 8:00 AM EDT Add to Favorites
Dr. Michael Birrer Named Recipient of the 2016 Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher
The Claudia Cohen Research Foundation and the Foundation for Women’s Cancer announced today that Michael J. Birrer, MD, PhD, has been selected as the 2016 recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic...
21-Mar-2016 8:00 AM EDT Add to Favorites
The Society of Gynecologic Oncology has appointed Pierre M. Désy, MPH, CAE, as Chief Executive Officer of the Society and its Foundation for Women’s Cancer, effective April 25, 2016.
22-Feb-2016 10:05 AM EST Add to Favorites
Gynecologic oncology research, education and awareness took a historic step forward on Jan. 1, 2016, when the Society of Gynecologic Oncology’s Foundation for Gynecology Oncology and the Foundation for Women’s Cancer (FWC) became one foundation...
4-Jan-2016 3:05 PM EST Add to Favorites
Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, has started his one-year term as the 47th President of the Society of Gynecologic Oncology (SGO) and fifth President of the Foundation for Gynecologic Oncology.
10-Apr-2015 11:05 AM EDT Add to Favorites
Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the...
27-Mar-2015 9:00 AM EDT Add to Favorites
Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing...
8-Jan-2015 1:00 AM EST Add to Favorites
The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to the Society of Gynecologic Oncology (SGO).
10-Dec-2014 4:30 PM EST Add to Favorites
11-Sep-2013 10:00 AM EDT
19-Jun-2013 12:00 PM EDT
14-May-2013 3:45 PM EDT
Cutting HPV Vaccine Costs to Poor Countries Should Spur More Vaccinations in US to Prevent Cervical Cancer
9-May-2013 11:45 AM EDT
SGO Expert Available to Discuss Study About Possible Use of Pap Test to Detect Ovarian and Endometrial (Uterine) Cancers
11-Jan-2013 8:15 AM EST